In this Supplement
Durable. Consistent. Safe.
Sustained durability of IN.PACT™ Admiral™ DCB treatment effect with no late catch-up through 2 years.
By Peter A. Schneider, MD
Drs. Virmani and Granada explain the importance of preclinical data, discuss key parameters for evaluation, and review the science behind clinical performance.
With Renu Virmani, MD, and Juan F. Granada, MD, FACC
A panel of experts discusses how the 2-year IN.PACT SFA and 1-year IN.PACT Global Study data affect decisions in real-world clinical practice.